OOIR: Observatory of International Research

Papers

(The H4-Index of Allergy is 53. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Issue Information	407
Type 2 memory B cells: The repository of allergic memory?	294
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	274
	237
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	235
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	167
In memoriam: Lawrence M. Lichtenstein (1934–2022)	160
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	157
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	151
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	148
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	147
Atopic Dermatitis ( AD ) Related Cord Blood DNA Methylation Patterns Are Linked to Maternal	145
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	139
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	127
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	126
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	124
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	123
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	112
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3	112
TOP10 ‐ SCAR : A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Rea	111
Transplacental Antimicrobial Antibodies and Childhood Asthma: Maternal Nativity as an Upstream Factor	98
Ficolin‐A Protects Against Allergic Asthma via Suppressing ILC2 ‐Drived Type 2 Inflammation	98
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	98
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP	93
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	90

Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	90
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	87
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	85
Type‐2‐Inflammatory‐Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade	83
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	83
Diet–Microbiome–Immune Interactions at the Gut Mucosa in Food Allergy: Mechanisms, Gaps, and Therapeutic Implications	81
Type I and II Interferons Drive Abacavir Hypersensitivity via Treg Suppression and T‐Cell Enhancement in Immunocompetent HLA	77
Interleukin‐22 and Interleukin‐18 as Potential Blood Biomarkers in Dupilumab‐Treated Atopic Dermatitis	77
Adherence to Mediterranean Diet During Pregnancy, Breastfeeding, and Development of Food Allergy in the Offspring: Results From the MEDALLION Cohort	75
Cryopreservation Between Sample Processing and Analysis in Streamlined Basophil Activation Test	73
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses	73
Non‐Releasers in the Basophil Activation Test: A Roadmap for the Correct Reporting and Interpretation	71
A Systematic Review and Meta‐Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Tas	68
Preclinical Development of GR2002 , a Novel Anti‐ TSLP Bispecific Antibody With Potent	64
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	63
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	63
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	61
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	61
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	60
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	59
Issue Information	58
Oral abstracts (OAS)	57
Issue Information	57
Issue Information ‐ TOC	57
Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function	55
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”	55
Issue Information	54
	54
Identification of Shared Regulators of IgE ‐ and MRGPRX2 ‐Dependent Degranulation in Human Mast Ce	53